Skip to main content
. 2022 Nov 23;13:1014854. doi: 10.3389/fphar.2022.1014854

TABLE 2.

Antiproliferative activity of compounds 5a, 5b, and 5c.

Cell lines IC50 (μM)
5a 5b 5c Irinotecan
HCT116 0.042 ± 0.04 0.045 ± 0.02 0.044 ± 0.02 5.15 ± 1.3
DLD1 6.08 ± 0.34 6.66 ± 0.42 6.16 ± 2.48 30.29 ± 3
HT29 2.18 ± 0.17 1.95 ± 0.07 2.05 ± 0.26 42.70 ± 2.01